allogeneic gm-csf-secreting breast cancer vaccine
Vaccineexperimental
Clinical trial activity
5 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00093834)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- allogeneic gm-csf-secreting breast cancer vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00971737 | Phase 2 | Jul 1, 2009 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00847171 | Phase 2 | Dec 1, 2008 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT00399529 | Phase 2 | Sep 1, 2006 | American Cancer Society, Inc., Avon Foundation, Cancer Treatment Research Foundation, Department of Defense, Genentech, Johns Hopkins University, The Commonwealth Fund |
| NCT00095862 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2004 | Wiseman Research Initiatives, LLC |
| NCT00093834 | Phase 1 | Jan 1, 2004 | Johns Hopkins University, National Cancer Institute (NCI) |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 4 | 4 | 2 | 2004 |
| National Cancer Institute (NCI) | Government | 3 | 0 | 2 | 2004 |
| American Cancer Society, Inc. | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Avon Foundation | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Cancer Treatment Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Department of Defense | Government | 1 | 0 | 1 | 2006 |
| Genentech | For profit | 1 | 0 | 1 | 2006 |
| The Commonwealth Fund | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Wiseman Research Initiatives, LLC | For profit | 1 | 1 | 1 | 2004 |
9 organizations
Page 1 / 1